We are Sorry, This Page doesn't Exist
Pfizer Plans To Offer COVID-19 Vaccine To Placebo Group Trial Volunteers: Report
Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) plan to allow the participants in the COVID-19 vaccine trials to learn if they were part of the placebo group and offer them free shots, read more.....»»
Medicago, GlaxoSmithKline report data from COVID-19 vaccine candidate trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Ampio"s Phase 1 long COVID-19 trial approved by Investigational Review Board
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Novavax initiates pediatric expansion for Phase 3 trial of COVID-19 vaccine
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Inovio stock plunges after U.S. government stops funding of Phase 3 trial of COVID-19 vaccine candidate
Shares of Inovio Pharmaceuticals Inc. plunged 29.7% toward a 13-month low, enough to pace all premar.....»»
Inovio sinks 26% after US government decides to discontinue funding for next phase of COVID-19 vaccine trial
"The decision results from the changing environment of COVID-19 with the rapid deployment of vaccines," said Inovio in a st.....»»
: French vaccine maker Valneva launches Phase 3 trial of its COVID-19 shot after snubbing EU
Valneva's Phase 3 trial will compare the immune response generated by its vaccine with that of the vaccine developed jointly by AstraZeneca and the University of Oxford.....»»
Dynavax: Valneva initiates Phase 3 trial for COVID-19 vaccine candidate
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
French vaccine maker Valneva to launch Phase 3 trial of COVID vaccine it"s making with Dynavax after positive results
Dynavax Technologies Corp. said Tu.....»»
Pfizer"s COVID-19 shot remains highly protective against the coronavirus, longer-term data shows
Six months after early trial participants got their second doses of the jab, Pfizer says the protection from its vaccine is strong and is holding up. A vial of Pfizer and BioNTech's coronavirus vaccine. CHRIS JACKSON/POOL/AFP.....»»
Pfizer and BioNTech say COVID-19 vaccine was 100% effective in Phase 3 trial in adolescents
Pfizer Inc. and German partner BioNTech SE said Wednesday that a Phase 3 trial of its COVID-19 vaccine in adolescents aged 12 to 15 showed 100% efficacy and robust antibody responses, an even better result than seen in an ea.....»»
UPDATE: Pfizer and BioNTech say COVID vaccine was 100% effective in Phase 3 trial of adolescents
Pfizer Inc. and German partner BioNTech SE said Wednesday a Phase 3 trial of its COVID-19 vaccine in adolescents aged 12 to 15 years old showed 100% efficacy and robust antibody responses, an even better result that seen in an.....»»
AstraZeneca Revises COVID-19 Vaccine Efficacy To 76% After Controversy
AstraZeneca Plc (NASDAQ: AZN) on Wednesday issued a fresh update of its phase three trial data for the COVID-19 vaccine after a U.S. read more.....»»
: AstraZeneca now says its COVID-19 vaccine is 76% effective
AstraZeneca PLC, which has been under fire for the accuracy of its data, on Wednesday night announced updated Phase 3 trial data of its coronavirus vaccine, saying it's 76% effective at preventing symptomatic COVID-19......»»
Dynavax doses first patient in Phase 2/3 trial for COVID-19 vaccine candidate
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
AstraZeneca Covid vaccine 79% effective in U.S. Phase III trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
AstraZeneca Phase 3 trial of COVID-19 vaccine candidate shows 79% efficacy
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»
Novavax"s COVID-19 vaccine candidate shows 96% efficacy in Phase 3 trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Novavax completes enrollment in Phase 3 clinical trial for its COVID-19 vaccine candidate
Shares of Novavax Inc. were down 6.2% in trading on Monday after the company said it had completed enrollment of the P.....»»
Cuba is working on a homegrown COVID-19 vaccine program. It has a history of fighting disease without help from the West
Cuba plans to launch the Phase 3 trial of the Soberana 02 vaccine in March.....»»